Merck & Co. Inc. buy Royal Bank of Canada
Start price
30.03.26
/
50%
€102.80
Target price
30.03.27
€123.30
Performance (%)
0.39%
Price
30.03.26
€103.20
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Merck & Co. Inc. is nearly unchanged. This prediction currently runs until 30.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Merck & Co. Inc. | 0.39% |
| iShares Core DAX® | -1.665% |
| iShares Nasdaq 100 | -3.766% |
| iShares Nikkei 225® | -2.803% |
| iShares S&P 500 | -2.299% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€105.40
25.02.26
25.02.26
€120.47
25.02.27
25.02.27
-2.09%
30.03.26
30.03.26
